Skip to content

Testosterone

Why we wait on testosterone.

We are waiting for the DEA telemedicine rule to settle before we open testosterone care. Until then it is waitlist only, and we do not have a date.

When it opens, it will start with a video visit with a licensed clinician, who decides whether treatment fits you and sets your lab schedule.

Phase 2

Why we wait.

Testosterone is a Schedule III controlled substance. A federal law, the Ryan Haight Act of 2008, generally requires an in-person medical exam before a controlled substance is prescribed online.

Since 2020, temporary federal flexibilities have let clinicians prescribe these medicines over telehealth without that exam. The current extension, from the DEA and HHS, runs through December 31, 2026. A permanent rule is not final yet.

We would rather build testosterone care on the permanent rule than on a temporary one. So we wait, and we will not promise a date.

Waitlist

Join the testosterone waitlist.

We will email you when testosterone care opens. No date yet.

What are you interested in?

How we handle health data: Consumer Health Data Privacy Policy

Meanwhile

What you can do now.

Read the official label for testosterone cypionate, see how a switch from another provider will work, or join early access for Baseline labs.